# Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy

> **NCT01567826** · PHASE4 · COMPLETED · sponsor: **Annapoorna Kini** · enrollment: 87 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** standard of care lipid therapy
- **DRUG:** Aggressive lipid therapy

## Key facts

- **NCT ID:** NCT01567826
- **Lead sponsor:** Annapoorna Kini
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2017-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01567826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01567826, "Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01567826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*